The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32531244.
- Also identified by DOI 10.1016/j.cell.2020.05.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Alzheimer's disease, obesity-related metabolic syndrome, and cancer are the leading causes of death and among the most costly medical conditions in the Western world. In all three cases, recent discoveries establish the TREM2 receptor as a major pathology-induced immune signaling hub that senses tissue damage and activates robust immune remodeling in response to it. In this review, we summarize and question what is known and remains to be discovered about TREM2 signaling pathway, track the consequences of its activation in physiological niches and pathological contexts, and highlight the promising potential of therapeutic manipulation of TREM2 signaling.
Medical subject headings
- Membrane Glycoproteins
- Signal Transduction